Anti-Mouse IFNAR1 Antibody (MAR1-5A3)
Based on 5 publication(s) in Google Scholar
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) is a neutralizing antibody of IFNAR1. Anti-Mouse IFNAR1 Antibody (MAR1-5A3) reacts with IFNAR1 and inhibits IFNAR1 signaling in vitro and in vivo. Mouse IgG1 kappa, Isotype Control (HY-P99977) is the isotype control of Anti-Mouse IFNAR1 Antibody (MAR1-5A3).
For research use only. We do not sell to patients.
- Purity: 99.39%
- Molecular Weight:150 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Anti-Mouse IFNAR1 Antibody (MAR1-5A3)
More-
In Vivo Efficacy Study
-
In Vivo Efficacy Study
-
In Vivo Efficacy Study
-
Histological Imaging/Staining
-
In Vivo Efficacy Study
Biological Activity
Mouse IgG1 kappa
Mouse
IFNAR1
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
in vivo IFNAR-1 blockade; in vitro IFNAR-1 blockade; Western blot; Flow Cytometry; ELISA
-
Immobilized IFNAR1 Protein, Mouse (HEK293, His, HY-P73127) can bind Anti-Mouse IFNAR1 Antibody (MAR1-5A3). The EC50 for this effect is 12.87 ng/mL.
Chemical Information
-
Appearance Liquid
-
Molecular Weight 150 kDa
-
Color Colorless to light yellow
-
SMILES
[Anti-Mouse IFNAR1 Antibody (MAR1-5A3)]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
Cell Mol Immunol
2025 Jan;22(1):83-96. PMID: 39627610
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) purchased from MedChemExpress. Usage Cited in: Cell Mol Immunol. 2025 Jan;22(1):83-96. [Abstract]
Schematic diagram of the application of 4-OHT to the ears of HO (Ppargfl/fl;Krt5creERT2/+) mice for 5 consecutive days, along with intradermal injections of neutralizing antibodies to IFNAR (HY-P99137; Anti-Mouse IFNAR1 Antibody (MAR1-5A3)) or anti-mouse IgG1 isotype controls (HY-P99977; Mouse IgG1 kappa, Isotype Control) on days 3 and 7 (intradermally administered 40 μl of a 2 mg/ml solution). Quantification and qualification of urine protein.
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) purchased from MedChemExpress. Usage Cited in: Cell Mol Immunol. 2025 Jan;22(1):83-96. [Abstract]
Schematic diagram of the application of 4-OHT to the ears of HO (Ppargfl/fl;Krt5creERT2/+) mice for 5 consecutive days, along with intradermal injections of neutralizing antibodies to IFNAR (HY-P99137; Anti-Mouse IFNAR1 Antibody (MAR1-5A3)) or anti-mouse IgG1 isotype controls (HY-P99977; Mouse IgG1 kappa, Isotype Control) on days 3 and 7 (intradermally administered 40 μl of a 2 mg/ml solution). The levels of anti-double-stranded DNA antibodies and antinuclear antibodies in the peripheral blood of the mice on day 17.
-
Nat Commun
2025 Apr 1;16(1):3140. PMID: 40169585
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Apr 1;16(1):3140. [Abstract]
The experiment was conducted in C57BL6/N mice with antagonists and antibodies (Anti-Mouse IFNAR1 Antibody (MAR1-5A3); ip; 250 μg/mouse dissolved in saline once daily for 4 weeks beginning with Ang II injection). Representative image of heart and wheat germ agglutinin (WGA) staining and quantification of WT with AngII, MT with AngII, MT with AngII and C-176, and MT with AngII and anti-IFNAR groups.
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Apr 1;16(1):3140. [Abstract]
The experiment was conducted in C57BL6/N mice with antagonists and antibodies (Anti-Mouse IFNAR1 Antibody (MAR1-5A3); ip; 250 μg/mouse dissolved in saline once daily for 4 weeks beginning with Ang II injection). Representative hematoxylin and eosin (H&E) staining and Masson’s trichrome staining showing heart size, cardiomyocyte size, and fibrosis in WT with AngII, MT with AngII, MT with AngII and C-176, and MT with AngII and anti-IFNAR groups.
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Apr 1;16(1):3140. [Abstract]
The experiment was conducted in C57BL6/N mice with antagonists and antibodies (Anti-Mouse IFNAR1 Antibody (MAR1-5A3); ip; 250 μg/mouse dissolved in saline once daily for 4 weeks beginning with Ang II injection). Quantification left ventricular end-diastolic anterior wall thickness (LVAW;d), left ventricular end-diastolic posterior wall thickness (LVPW;d), Ejection fraction (EF), Fractional shortening (FS) or left ventricular (LV) mass.
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Apr 1;16(1):3140. [Abstract]
The experiment was conducted in C57BL6/N mice with antagonists and antibodies (Anti-Mouse IFNAR1 Antibody (MAR1-5A3); ip; 250 μg/mouse dissolved in saline once daily for 4 weeks beginning with Ang II injection). Representative M-mode echocardiograms of the left ventricle in WT with AngII, MT with AngII, MT with AngII and C-176, and MT with AngII and anti-IFNAR groups.
-
Nat Commun
Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB. [Abstract]2025 Jan 8;16(1):496. PMID: 39779683 -
Int Immunopharmacol
Intratumoral microbiota-driven macrophage reprogramming in pancreatic cancer via Blautia metabolite 6-hydroxyhexanoic acid. [Abstract]2025 Oct 30:164:115421. PMID: 40865404 -
Purity & Documentation
-
Data Sheet (260 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Macal M, et al. Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection. Immunity. 2018 Apr 17;48(4):730-744.e5. [Content Brief]
[2]. Schliehe C, et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol. 2015 Jan;16(1):67-74. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)